ACTION

📣 New! Results UK advocacy report - Stigma kills: Why medicines alone won’t end tuberculosis

TB is a complex disease that still affects over 10 million people worldwide every year. The causes and drivers of TB such as poverty, undernutrition, stigma, and inadequate healthcare infrastructure limit individuals and communities in being able to access effective diagnostic tests and treatments for TB. A lack of political will and funding for TB research and development is further impeding progress to end TB by 2030.

Addressing the social and economic complexities of TB requires an equity approach that integrates healthcare within broader efforts to tackle poverty, inequality, stigma and structural barriers to health access. Governments have a responsibility to prioritise health equity by adopting a whole of society approach. By valuing health as a global public good to benefit all people, the planet and the economy, and ensure no one is left behind.

The UN political declaration on TB specifically calls for “relevant stakeholders to pursue actions to end tuberculosis and leave no one behind through a whole of society and whole of government approaches”. To accelerate progress to end TB we must develop policies and interventions that target the root causes of TB, in addition to medical interventions.

This report presents the case for adopting a whole of society approach to ending TB. The report provides recommendations for governments, policymakers and national TB programmes around the world, focused on addressing the underlying social causes of TB alongside curing the physical disease.

Read the full report here: https://results.org.uk/publication/stigma-kills-why-medicine-alone-wont-end-tuberculosis/

stigma kills: why medicine alone won’t end tuberculosis – Results UK Tuberculosis (TB) is a complex disease that still affects over 10 million people worldwide every year. The causes and drivers of TB such as poverty, undernutrit

At this very moment, countries are applying for funding from the Global Fund’s Grant Cycle 7 (GC7). Of the US$15.7 billion raised at the Global Fund’s 2022 pledging conference, $2.442 billion is set to go to TB efforts over the next three years through country grants and matching funds. While this is a $154.2 million increase over the last round of funding, it still comes nowhere near to covering the tremendous need.

Countries have started submitting their national three-year plans and it’s clear that they are developing some of the most ambitious plans in history. However, financing gaps are glaring. The cost of virtually all country plans is well above the money available to fund them.

Applications to the Global Fund come in windows, with a total of 92 countries eligible for TB funding for the next three-year period. In the first three windows of submissions — just 63 countries — the gap between expressed need and available funding was already well over 𝗨𝗦$𝟭.𝟭 𝗯𝗶𝗹𝗹𝗶𝗼𝗻.

Read more: https://bit.ly/TBgaps